Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).

Source:http://linkedlifedata.com/resource/pubmed/id/19461584

Download in:

View as

General Info

PMID
19461584